Head-To-Head Survey: iSpecimen (NASDAQ:ISPC) versus Standard BioTools (NASDAQ:LAB)
Standard BioTools (NASDAQ:LAB – Get Free Report) and iSpecimen (NASDAQ:ISPC – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations. Insider and Institutional Ownership 53.7% of Standard BioTools […]
16 Aug 02:14 · The Markets Daily